Psoriasis Clinical Trial

LTS of Siliq vs. Other Therapies Treating of Adults With Moderate-to-Severe Psoriasis

Summary

Prospective, Observational Study to Assess the Long-Term Safety of Brodalumab Compared with Other Therapies in the Treatment of Adults with Moderate-to-Severe Psoriasis

View Full Description

Full Description

Prospective, Observational Study to Assess the Long-Term Safety of Brodalumab Compared with Other Therapies in the Treatment of Adults with Moderate-to-Severe Psoriasis Who Are Candidates for Systemic Therapy or Phototherapy in the Course of Actual Clinical Care

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Diagnosis and main criteria for inclusion: a subject must have moderate to severe psoriasis diagnosed by a dermatologist
Must be at least 18 years of age or older
Started on or switched to a systemic psoriasis treatment within the previous 12 months. FDA-approved biologic treatments and select non-biologic treatments (eg, methotrexate, cyclosporine, or apremilast only) are permitted.

Exclusion Criteria:

The subject is unable or unwilling to provide informed consent to participate in the registry.
The subject is participating or planning to participate in a clinical trial with a non-marketed or marketed investigational drug (i.e. Phase I-IV drug trial).
The subject is restarting the eligible medication less than 12 months since receiving the last dose.

Study is for people with:

Psoriasis

Estimated Enrollment:

3500

Study ID:

NCT03254667

Recruitment Status:

Enrolling by invitation

Sponsor:

Bausch Health Americas, Inc.

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Registry
Bridgewater New Jersey, 08807, United States

How clear is this clinincal trial information?

Study is for people with:

Psoriasis

Estimated Enrollment:

3500

Study ID:

NCT03254667

Recruitment Status:

Enrolling by invitation

Sponsor:


Bausch Health Americas, Inc.

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.